Rejuveinate LLC

Rejuveinate LLC was paid $218K by Medicaid between Oct 2021 and Jul 2022, across 4 billing codes. Its largest line is M0244, Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency — 78% of everything it billed.

33Billing provider infoREJUVEINATE LLC
BERGENFIELD, NJ 07621

33aNPI1952962169assigned 06/27/2019

33bProvider typeAnesthesiology Physician

28Total paid$218K

24GClaims439

24DCodes billed4

24AFirst – last monthOct 2021 – Jul 2022

Compared with peers

Next to other Anesthesiology Physician providers in New Jersey

Rank by total paid#19 of 85

Median peer was paid$20K

This provider vs. median11×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2021	239	$155K
2022	200	$62K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
M0244	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency	78%	270	263	$170K
M0246	Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider based to the hospital during the covid 19 public health emergency	10%	56	51	$22K
M0223	Intravenous injection, bebtelovimab, includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency	9.5%	89	85	$21K
M0248	Intravenous infusion, sotrovimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency	2.3%	24	22	$5K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLEHMAN, ABRAHAM (AUTHORIZED REPRESENTATIVE)

Same official

Other billing entities under LEHMAN, ABRAHAM

Full network →

Provider	Location	Paid
Fallsview Medical LLP	Brooklyn, NY	$74K
Abraham R Lehman MD, LLC	Bergenfield, NJ	$16K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.